Sign in
4

Changes in Ownership

Lineage Cell Therapeutics, Inc. Filed Acc 0000919574-22-002418

Director bought 930,106 shares at an average $1.42 ($1,317,667)

From the SEC's structured data for this filing

Trades in this filing

BROADWOOD PARTNERS, L.P. · Director

Table I: Non-derivative

6 lines
Date Transaction Shares Price Value Owned after D/I
2022-03-23 Purchase : show line 1 in the form +260,106 $1.37 $355,305 34,265,485 D
2022-03-23 Purchase : show line 2 in the form +0 34,265,485 I
2022-03-24 Purchase : show line 3 in the form +200,000 $1.42 $284,340 34,465,485 D
2022-03-24 Purchase : show line 4 in the form +0 34,465,485 I
2022-03-25 Purchase : show line 5 in the form +470,000 $1.44 $678,022 34,935,485 D
2022-03-25 Purchase : show line 6 in the form +0 34,935,485 I
Open-market purchases · 930,106 sh · avg $1.42 · $1,317,667
Loading xslF345X03/ownership.xml…